Handa Pharmaceuticals (Taiwan) Probability of Future Stock Price Finishing Under 55.91

6620 Stock  TWD 54.60  2.10  3.70%   
Handa Pharmaceuticals' future price is the expected price of Handa Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Handa Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Handa Pharmaceuticals Backtesting, Handa Pharmaceuticals Valuation, Handa Pharmaceuticals Correlation, Handa Pharmaceuticals Hype Analysis, Handa Pharmaceuticals Volatility, Handa Pharmaceuticals History as well as Handa Pharmaceuticals Performance.
  
Please specify Handa Pharmaceuticals' target price for which you would like Handa Pharmaceuticals odds to be computed.

Handa Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Handa Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Handa Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Handa Pharmaceuticals generated a negative expected return over the last 90 days
The company reported the revenue of 28.86 M. Net Loss for the year was (282.1 M) with profit before overhead, payroll, taxes, and interest of 68.71 M.
Handa Pharmaceuticals has accumulated about 315.09 M in cash with (308.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72.

Handa Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Handa Stock often depends not only on the future outlook of the current and potential Handa Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Handa Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume Last 10 Day199.54k
Average Daily Volume In Three Month158.6k

Handa Pharmaceuticals Technical Analysis

Handa Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Handa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Handa Pharmaceuticals. In general, you should focus on analyzing Handa Stock price patterns and their correlations with different microeconomic environments and drivers.

Handa Pharmaceuticals Predictive Forecast Models

Handa Pharmaceuticals' time-series forecasting models is one of many Handa Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Handa Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Handa Pharmaceuticals

Checking the ongoing alerts about Handa Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Handa Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Handa Pharmaceuticals generated a negative expected return over the last 90 days
The company reported the revenue of 28.86 M. Net Loss for the year was (282.1 M) with profit before overhead, payroll, taxes, and interest of 68.71 M.
Handa Pharmaceuticals has accumulated about 315.09 M in cash with (308.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72.

Additional Tools for Handa Stock Analysis

When running Handa Pharmaceuticals' price analysis, check to measure Handa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Handa Pharmaceuticals is operating at the current time. Most of Handa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Handa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Handa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Handa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.